Matrixyl 3000 vs Matrixyl Synthe'6: Which Anti-Aging Peptide Wins? (UAE Guide 2026)
Share
Matrixyl 3000 vs Matrixyl Synthe'6: Which Peptide Should You Use? UAE 2026
Matrixyl 3000 and Matrixyl Synthe'6 are both from the Matrixyl peptide family but work through different mechanisms and target different skin aging patterns. Matrixyl 3000 (two peptides: Pal-GHK + Pal-GQPR) is best for prevention, fine lines, and overall skin quality maintenance. Matrixyl Synthe'6 (palmitoyl tripeptide-38) stimulates six matrix components including hyaluronic acid — best for deep wrinkle correction and intensive aging reversal. For most UAE patients over 35, using both together provides maximum anti-aging benefit.
Palmitoyl Tripeptide-1 + Palmitoyl Tetrapeptide-7
- Collagen I, III, IV stimulation
- Elastin production support
- Fibronectin upregulation
- Glycation inhibition (anti-AGE)
- IL-6 suppression → less UV-driven MMP activity
- Best for: prevention, fine lines, overall texture
Palmitoyl Tripeptide-38
- Collagen I, III, IV stimulation
- Fibronectin stimulation
- Hyaluronic acid synthesis
- Laminin-5 upregulation
- Six ECM components simultaneously
- Best for: deep wrinkles, intensive correction
The Core Difference: Why Two Matrixyls Exist
When Sederma developed Matrixyl 3000, the primary goal was to extend the matrikine concept beyond the original single-peptide Matrixyl into a more comprehensive two-component system that could address collagen and anti-glycation simultaneously. The addition of palmitoyl tetrapeptide-7 (Pal-GQPR) alongside palmitoyl tripeptide-1 (Pal-GHK) was specifically designed to provide anti-inflammatory benefits against the chronic low-grade inflammation (inflammaging) that drives much of age-related collagen breakdown.
Matrixyl Synthe'6 was developed years later with a more ambitious brief: not just to stimulate collagen and inhibit inflammation, but to rebuild the entire ECM architecture — including components like hyaluronic acid and laminin-5 that Matrixyl 3000 does not directly stimulate. The single peptide palmitoyl tripeptide-38 was engineered to activate a broader array of matrix-producing pathways simultaneously.
Understanding which one to use — and when to use both — requires understanding what each targets and why those targets matter for your specific skin concern.
Matrixyl 3000: A Deep Dive
Component 1: Palmitoyl Tripeptide-1 (Pal-GHK)
The GHK (Glycine-Histidine-Lysine) tripeptide is one of the most studied skin-signalling molecules in cosmetic science. It occurs naturally as a breakdown fragment of collagen type I and is found in human plasma — with concentration declining from approximately 200 ng/ml at age 20 to approximately 80 ng/ml at age 60. This age-related decline is directly correlated with reduced skin repair capacity.
In its palmitoylated form, GHK penetrates the stratum corneum more effectively and reaches dermal fibroblasts where it activates multiple repair and protection pathways:
- Collagen synthesis: Fibroblast upregulation of procollagen type I and III mRNA — increasing production of the primary structural collagens
- MMP inhibition: Reduces expression of MMP-1 (collagenase), MMP-2 (gelatinase A), and MMP-9 (gelatinase B) — enzymes that break down existing collagen
- TIMP upregulation: Increases tissue inhibitors of metalloproteinases, which directly protect existing collagen from enzymatic degradation
- Wound healing: Activates keratinocyte migration and epidermal repair — accelerating recovery from any surface damage
- Anti-inflammatory: Reduces TNF-α expression in stressed skin cells, complementing LZ1's anti-inflammatory benefit in acne-adjacent contexts
Component 2: Palmitoyl Tetrapeptide-7 (Pal-GQPR)
Palmitoyl tetrapeptide-7 (GQPR = glycine-glutamine-proline-arginine) was developed specifically to address the inflammatory driver of age-related skin deterioration — what is sometimes called "inflammaging": the chronic, low-grade, subclinical inflammation that runs in the dermis without producing visible lesions but continuously activates collagen-degrading MMPs.
Primary mechanisms:
- IL-6 inhibition: Suppresses interleukin-6 signalling, which is a key activator of the MMP cascade in UV-stressed skin. In the UAE's intense UV environment, where chronic UV exposure continuously activates AP-1 transcription factors and drives IL-6 production, this anti-IL-6 effect of Matrixyl 3000 is particularly valuable
- Glycation inhibition: Reduces non-enzymatic cross-linking of collagen and elastin fibres by sugars — the process that makes aged skin feel stiff and leathery rather than supple. Advanced glycation end-products (AGEs) accumulate in skin from sugar exposure and UV radiation; Pal-GQPR partially inhibits AGE formation
- UV stress protection: Modulates the keratinocyte response to UV challenge, reducing the post-UV inflammatory spike that drives photoaging acceleration
Why Matrixyl 3000 Is the Standard for Prevention
The combination of Pal-GHK's collagen synthesis promotion + MMP/TIMP modulation and Pal-GQPR's IL-6 inhibition + glycation protection creates a comprehensive maintenance protocol for skin that is not yet showing severe aging but needs protection against the rate of collagen loss. This is why Matrixyl 3000 is the most widely recommended anti-aging peptide for adults in their late 20s through early 40s who are in prevention mode rather than reversal mode.
Sederma's clinical evidence supports this: the 45% wrinkle depth reduction at 2 months is a correction result achieved under study conditions, but for ongoing prevention use (starting younger, before deep lines form), the inhibition of MMP activity and glycation provides a protective benefit that prevents lines from deepening in the first place.
Matrixyl Synthe'6: A Deep Dive
Palmitoyl Tripeptide-38: The Six-Component Activator
The design philosophy behind palmitoyl tripeptide-38 was fundamentally different from Matrixyl 3000. Rather than combining two existing functional peptides, Sederma's research team developed a novel peptide sequence specifically engineered to activate a broader set of matrix synthesis pathways through a single molecule.
Palmitoyl tripeptide-38 stimulates the synthesis of six critical matrix components:
1–4: Collagen I, III, IV and Fibronectin
These four components are also targeted by Matrixyl 3000, but the specific activation pathways used by tripeptide-38 are different from those of Pal-GHK and Pal-GQPR. The result is stimulation through additional signalling routes that can act synergistically when Synthe'6 is combined with Matrixyl 3000.
5: Hyaluronic Acid
This is the most important unique feature of Matrixyl Synthe'6. Hyaluronic acid (HA) is the primary water-binding molecule in the dermis — each HA molecule can hold up to 1000× its own weight in water. Dermal HA concentration declines dramatically with age and UV exposure, contributing directly to the loss of skin plumpness, volume, and the visual "deflation" that characterises aged skin.
Matrixyl 3000 does not stimulate HA synthesis. Matrixyl Synthe'6 does — making it the only Matrixyl generation that addresses the hydration component of skin aging at the structural level, not just through moisturiser application. This intrinsic HA synthesis stimulation is what makes Synthe'6 produce a visible "plumping" effect on the skin that Matrixyl 3000 does not achieve to the same degree.
6: Laminin-5
Laminin-5 is a component of the dermal-epidermal junction (DEJ) — the structural interface between the dermis and epidermis. With aging, the DEJ flattens and laminin-5 concentration in the basement membrane decreases. This produces visible consequences: loss of the sharp skin surface microstructure, reduced skin density (the skin feels less firm when you press it), and eventually the slight transparency that characterises severely aged skin.
No other commonly used cosmetic peptide directly stimulates laminin-5 synthesis. Synthe'6's ability to rebuild the DEJ is one of its most architecturally meaningful contributions to skin quality — and it explains why users often describe Synthe'6-treated skin as having a more "structural" feel than Matrixyl 3000 alone provides.
Head-to-Head: Full Clinical Comparison
| Feature | Matrixyl 3000 | Matrixyl Synthe'6 |
|---|---|---|
| Peptide composition | Two peptides: Pal-tripeptide-1 (GHK) + Pal-tetrapeptide-7 (GQPR) | One peptide: Pal-tripeptide-38 |
| Matrix targets | Collagen I/III/IV, elastin, fibronectin, GAGs | Collagen I/III/IV, fibronectin, hyaluronic acid, laminin-5 |
| Unique advantage | Glycation inhibition + IL-6 suppression | Hyaluronic acid synthesis + laminin-5 (DEJ repair) |
| Wrinkle reduction evidence | Up to 45% depth reduction (Sederma, 2 months, 3%) | "Pronounced" reduction in deep wrinkles (Sederma) |
| Elasticity improvement | 20% improvement (Sederma study) | Broader matrix support provides firming effect |
| Best skin concern | Fine lines, prevention, overall texture/firmness | Deep wrinkles, skin volume, intensive correction |
| Best age range | Late 20s through mid-40s (prevention + early correction) | 40s+ for deep correction; all ages with Matrixyl 3000 |
| Recommended concentration | 3–10% in topical serums | 1–3% in topical serums |
| Can be combined? | Yes — complementary pathways, synergistic together | |
Which One Is Right for You?
Choose Matrixyl 3000 if:
- You are in your late 20s or 30s and focused on prevention — slowing collagen loss before visible lines form
- Your primary concern is skin texture, pore appearance, and early fine lines
- You live and work in intense sun exposure (UAE) and want anti-inflammatory + anti-glycation protection against photoaging
- You are new to peptide skincare and want a well-characterised, high-evidence starting point
- Your skin responds well to lighter serums without the additional plumping effect of HA stimulation
Choose Matrixyl Synthe'6 if:
- You have established deep wrinkles — nasolabial folds, forehead lines, crow's feet — that fine-line treatments haven't adequately addressed
- Your skin has lost volume and the "plump" quality it had in earlier years
- You have sun-damaged skin from years of UAE UV exposure where structural collagen IV and laminin-5 damage is likely
- You want additional intrinsic HA stimulation beyond what topical HA serums can provide (topical HA sits on the surface; Synthe'6-stimulated HA is produced in the dermis)
- You are 45+ and focused on reversal rather than prevention
Use Both if:
- You are 35–55 and want the maximum comprehensive anti-aging protocol
- You have a combination of fine line maintenance needs AND some deeper wrinkle correction goals
- You can apply Matrixyl 3000 in the morning and Synthe'6 in the evening — covering prevention during the day and intensive repair overnight
Recommended UAE Protocol: Use Both
Morning: Matrixyl 3000 serum (3%+) → SPF 50+. The IL-6 inhibition and glycation protection of Matrixyl 3000 provide daytime photoaging defence.
Evening: Matrixyl Synthe'6 serum (1–3%) → moisturiser. Synthe'6's six-component stimulation works overnight when skin is in peak repair mode and cortisol-driven collagen breakdown is at its daily minimum.
The UAE Photoaging Factor: Why Synthe'6 Matters More Here
The UAE's intense UV environment (UV Index 9–11+ for 6 months of the year) creates specific patterns of skin aging that make Matrixyl Synthe'6's unique targets — particularly hyaluronic acid and laminin-5 — especially relevant.
UV and Hyaluronic Acid Degradation
UV radiation activates hyaluronidases — enzymes that degrade hyaluronic acid in the dermis. Chronic UAE sun exposure accelerates dermal HA turnover significantly compared to low-UV environments. This drives the characteristic "hollow" appearance of severely photodamaged skin — the facial volume loss that is more about HA depletion than fat loss, and that cannot be adequately addressed by injectable HA fillers alone without also addressing the underlying accelerated HA degradation.
Matrixyl Synthe'6's HA synthesis stimulation addresses this at the production side: increasing the rate of endogenous HA synthesis to help offset UV-accelerated degradation.
UV and Basement Membrane Damage
UV radiation specifically damages the dermal-epidermal junction — degrading collagen IV and laminin-5 through UV-activated MMPs. This basement membrane degradation is one of the earliest structural changes in photoaging and contributes to the "blurring" of sharp skin features that characterises sun-damaged skin.
Synthe'6's laminin-5 stimulation directly addresses this photoaging-specific damage pattern. No other commonly available cosmetic peptide targets the basement membrane as specifically. For UAE residents with moderate to significant photoaging, this makes Synthe'6 not just a nice addition but a structurally important intervention.
Matrixyl Concentrations: What Works and What Doesn't
| Concentration | Matrixyl 3000 | Matrixyl Synthe'6 |
|---|---|---|
| Under 1% | Minimal visible benefit; appropriate only for mild adjunct effect | Minimal visible benefit |
| 1–3% | Effective for maintenance; some wrinkle improvement over time | Full clinical range — effective at 1% for Synthe'6 |
| 3–10% | Full clinical range — matches Sederma study conditions | Upper therapeutic range; used in some intensive formulas |
| Injectable (e.g., Matrixyl 20mg) | Direct dermal delivery — maximum bioavailability, bypasses penetration barrier | Same injectable advantage |
Frequently Asked Questions
Related Products Available at Core Sup

CoreSup stocks pharmaceutical-grade bacteriostatic water (10ml, 0.9% benzyl alcohol) with same-day delivery across Dubai and all UAE emirates.
Shop Bacteriostatic Water →Written by Amir Arsalan
Core Sup Research Team · Peptide & Supplement Specialists, Dubai UAE
Core Sup's editorial team is composed of specialists in peptide therapy, SARMs, and sports supplementation with direct experience in the UAE market. All content is written to current research standards and reviewed before publication.
Last reviewed: April 2026 · About Core Sup



